Black Diamond Therapeutics Inc (NASDAQ:BDTX) traded at $2.87 at close of the session on Friday, July 11 and made an upward move of 4.74% on its previous day’s price.
Looking at the stock we see that its previous close was $2.74 and the beta (5Y monthly) reads 2.712 with the day’s price range being $2.7 – $2.875. The company has a trailing 12-month PE ratio of 46.52. In terms of its 52-week price range, BDTX has a high of $6.75 and a low of $1.20. The company’s stock has gained about 16.67% over that past 30 days.
Black Diamond Therapeutics Inc has a market cap of $163.20 million and is expected to release its quarterly earnings report on 2025-May-12.
On the other hand, looking at the outlook for the BDTX stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 50% Buy.
Based on estimates by 3 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Black Diamond Therapeutics Inc (BDTX) stock as a Hold, while 3 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note that the PEG ratio for the BDTX stock currently stands at 8.61, and the current price level is 15.59% off its SMA20 and 29.32% from its 50-day simple moving average. The RSI (14) is pointing at 68.91 while the volatility over the past week is 5.67% and jumps to 7.09% over the past one month. The average price target for the stock over the next 12 months is $14, with the estimates having a low of $11 and a high of $20. These price ends are -283.28% and -596.86% off the current price level respectively, although investors could be excited at the prospect of a -387.8% if the BDTX share price touches on the median price of $14.
Coming back to Black Diamond Therapeutics Inc (NASDAQ:BDTX), we note that the average 3-month trading volume was 1.13 million, while that of the preceding 10-day period stands at 1.48 million. Current shares outstanding are 56.68 million.
The insiders hold 23.88% of the company’s shares while institutions hold 61.99%. The data shows that short shares as of 2025-06-13, stood at 6.84 million at a short ratio of 5.2. This represents a 1727.00 short interest in shares outstanding on 2025-06-13. Shares short fall in June from the previous month at 8.08 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -42.71% down in year-to-date price movement.
